High-resolution revolution. by Manuel, John
High-Resolution
Revolution
Every so often, a technology emerges that
revolutionizes a field of scientific study.
Magnetic resonance microscopy (MRM),
being developed by the Duke University
Center for In Vivo Microscopy in conjunc-
tion with the NIEHS, promises to do just
that for the field of toxicologic pathology.
“This tool will allow us to explore the full
potential of animal models,” says G. Allan
Johnson, director of the center. “It will
bring us dramatically closer to identifying
the environmental factors that contribute to
human disease.”
MRM is an evolution of magnetic reso-
nance imaging (MRI), which has been used
in clinical settings since the early 1980s. Both
employ powerful magnets to beam radiofre-
quency signals through the body, causing
hydrogen atoms in soft tissue to resonate. A
computer detects this resonance, which varies
according to factors such as water content,
and produces an image that pathologists and
radiologists can use to differentiate healthy
versus diseased tissue. MRM differs from
MRI in that it works with a much stronger
magnetic field and delivers images at more
than 250,000 times greater resolution. MRM
is used exclusively to scan small animals, with
a focus on rodents as an animal model for
human disease.
Imaging Evolution
Researchers at Duke have been refining
MRM since 1986, employing ever-stronger
magnets, larger imaging arrays, and more
sensitive radiofrequency receivers. The center
can image a whole mouse at a resolution of
100 microns (the width of a human hair is
about 200 microns) using a 2.0-T (tesla)
magnet. (A tesla is a unit of strength of a
magnet.) A 7-T magnet is used to image a
part of the body at a resolution of 50
microns. Using their most powerful device, a
9.4-T magnet, the center can scan individual
organs at a resolution of 25 microns.
“The people at the center are doing really
impressive work,” says W. Thomas Dixon,
physicist at General Electric’s Global
Research Center in Niskayuna, New York,
which has helped Duke modify General
Electric imaging consoles for use with MRM.
“It was originally believed you couldn’t get
decent contrast at high fields of resolution,
but they have proven that wrong.”
Both live and dead animals can be
imaged with MRM. Motion will degrade the
signal, which limits the use of live animals for
high-resolution scanning. Although live ani-
mals are anesthetized, they may make slight
movements during scanning periods, which
last anywhere from 20 minutes to more than
an hour. Johnson and colleagues have been
able to compensate for the motion of heart
and lungs by synchronizing the signal with
the animal’s heartbeat and breathing.
During the imaging process, data are
produced in digital form, transferred to a
computer, and displayed on a conventional
desktop monitor. The images are isotropic,
that is, are of equal resolution in three
dimensions and can be turned on any angle.
Researchers can “slice” the image along any
plane and proceed through hundreds of slices
in a minute. Robert Maronpot, chief of the
Laboratory of Experimental Pathology at the
NIEHS and a collaborator with Johnson in
the development of MR histology (the study
of the structure and chemical composition of
animal tissues as related to their function),
says the ability to manipulate imagery
through MRM is unprecedented.
“Using conventional pathology, it
would take weeks of sectioning to get 10
micron slices of an entire mouse brain,” he
says. “That would produce approximately
2,000 slides that
would then have
to be examined
by a pathologist.
Even then, you
would only be
dealing with two
dimensions. It
would take at
least a year to
reconstruct the
brain in three
dimensions from
the 2,000 slides.
MRM can do all
this in an hour-
long scan at a
fraction of the
cost.” Johnson
estimates the cost
to recreate a
mouse brain in
three dimensions
using convention-
al pathology at
roughly $60,000;
with MRM it
would be $2,000.
However, he says
a strict compari-
son is not possi-
ble because “you
could never match
up the slides using conven-
tional pathology as you can
with MRM.”
Maronpot says MRM will
not replace conventional
pathology, but rather comple-
ment it. “MRM will lead us to
prudently select sample sites
for traditional pathology,” he
says. “The latter is still needed
to look at individual cells and
characterize lesions.”
Advances in the field of
MR histology are being made
possible not just through the
development of better hard-
ware, but also by improved
stains (MR contrast agents).
Before an animal is scanned
for MRM, it is perfused with
a fixative containing a stain
that selectively alters or
enhances certain properties of
the tissue in a way that
improves the scanned images.
Different paramagnetic com-
pounds are used as stains,
depending upon what proper-
ties researchers want to high-
light. Johnson and colleagues
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Gazing inward. A magnetic resonance microscope, developed
by the Duke University Center for In Vivo Microscopy in conjunc-
tion with the NIEHS, allows scientists a clear picture of the inner
workings of small animals, particularly rodents.have had particular success using formalin
laced with gadolinium—a highly magnetic
rare earth element—for imaging soft tissue.
Coincident with the improvement in
hardware and fixation/perfusion methods has
been the development of computing power
needed to process the vast amount of data
produced by MRM. Imaging of a single
mouse produces eight gigabytes of data.
Acquiring the computing power to scan and
store data on the millions of rodents being
produced for research is one of the major
challenges of MRM. Johnson and colleague
Robert Lontz have founded a company,
MRPath, Inc., to offer MRM scanning ser-
vices and viewing software to the larger
research community.
Targeting Tissues
According to Maronpot, MRM has immedi-
ate application in the field of developmental
biology and toxicologic research, allowing
researchers to follow the progression and
regression of toxic and carcinogenic processes
in animal models more thoroughly and more
easily than with conventional pathology.
Maronpot says the arrival of this technology
is particularly timely, given the number of
genetically engineered mice being produced
for research. “It would be totally impractical
to employ conventional histopathology to
phenotype all these mice,” he says. “With
MRM, we have a better chance.”
Maronpot says MRM may allow
researchers to use fewer animals, given that
one can more thoroughly analyze each ani-
mal, and when imaging live animals, the
same animal can be followed over the pro-
gression of the study without the need to
kill it. “You can even use the same animal as
its own control,” he says, because with this
technology the animal can also be examined
for preexisting tumors before it is exposed
to test substances.
Eric Wisner, a professor of surgical and
radiologic sciences at the University of
California at Davis, sees other advantages
to MRM. “In addition to examining tis-
sues, MRM is very good at functional
imagery, things like blood flow and fluid
perfusion and diffusion,” he says. “I think
you will see these techniques growing along
with the phenotyping of genetically engi-
neered animals.”
Currently, the NIEHS is involved in
three studies using MRM on fixed speci-
mens. Robert Sills, head of Molecular
Pathology at the NIEHS, is using MRM to
study the effects of carbonyl sulfide in rats.
Carbonyl sulfide is a by-product of many
industrial processes and is listed as a chemi-
cal of concern under the Clean Air Act.
The U.S. Environmental Protection
Agency (EPA) has nominated the chemical
for study regarding three possible effects:
on the nervous system, on reproductive
and developmental processes, and on can-
cer development. Rats have been exposed
to the compound and scanned at the
Center for In Vivo Microscopy. Using
MRM to scan the whole brain, researchers
have found lesions where they never
expected to find them.
“MRM has greatly increased what we
can do in this study,” Sills says. “Because
the brain is still intact, we can go back and
make assessments as to how large an area of
the brain is involved, differences in terms
of exposure, and how the lesions progressed
over time. We can look at the brain not
only in cross sections, but also longitudinal
sections, which might reveal other areas
involved. It’s a very exciting tool.”
Maronpot is principal investigator of a
second study examining birth defects in
rats exposed to high levels of vitamin A.
This pilot study examined the use of MRM
in teratology, rather than investigating the
toxicity of vitamin A. In the study, preg-
nant rats were exposed to the compound,
and their pups were delivered by caesarian
section. The pups were processed using fix-
ative containing paramagnetic gadolinium
and then examined by MRM. “This pilot
study has enabled us to work out the best
imaging parameters,” Maronpot says.
“We’ve now refined the MRM procedures
and are ready to do a complete study.”
Maronpot is also involved in a study
with the EPA on the health effects of
ammonium perchlorate. This chemical is a
primary ingredient in solid propellant for
rockets, missiles, and fireworks. Perchlorate
is exceedingly mobile in water systems and
can persist for many decades under typical
groundwater and surface water conditions.
It is manufactured in 44 states, and 14
states currently have confirmed releases in
ground and surface waters. Although there
is no national primary drinking water regu-
lation for perchlorate, the chemical is
known to be toxic at some level, inhibiting
the uptake of iodide in the thyroid. In this
study, breeding pairs of rats are exposed to
perchlorate via drinking water, and their
pups were exposed through nursing.
Maronpot and Johnson are scanning the
pups’ brains for neurotoxicologic defects
using MRM. The EPA will then do an
evaluation of the images. “With MR histol-
ogy, we can examine the whole brain and
get a much more accurate assessment of the
effects than we could with conventional
pathology,” Maronpot says.
Asked where MRM technology will be
in five years, Johnson says, “I think we can
get down to 10-micron isotropic resolu-
tion. We are working with a company to
build more sensitive radio receivers. We are
also looking at intelligent ways to use all
the data generated by this technology.”
Johnson continues, “The imaging game
is just starting to catch on for small animal
research. We are going to see some dramat-
ic advances in the coming years.”
John Manuel
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The inside story. Robert Maronpot of the NIEHS (left) and Allan Johnson of Duke University
(right) examine the results of a mouse scanned using magnetic resonance microscopy. Such scans
will offer insights into the mechanisms by which environmental agents cause cancer tumors and
other adverse effects.
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